Tuesday, November 01, 2016 4:14:57 PM
You say this is the only way Hartmann can raise cash, where is the rest of the needed cash going to come from? I keep hearing JV, but what company is going to partner with a bio that doesn't have a patent on their wonder drug? Until a patent there won't be a legitimate JV, and until there's a JV they can't possibly even begin to pay for the paperwork to move into real trials. The light shown on the patent issues recently is a lot more important than I see anyone comment on. I don't wish anyone losses, I only wish everyone makes cash hand over fist and I hope that tomorrow Hartmann announces they are bought by Pfizer or signed an agreement with Glaxo, but I really don't think that's the case.
I think they are in a more troublesome spot then you seem to let on. There's dilution, then there's a pump with a 70% value loss in 25 days.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM